This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer.

H – His – Tyr – Leu – Ser – Thr – Gln – Ser – Ala – Leu – OH

≥ 95%

-20°C

HYLSTQSAL

Wysocki, P. et al. Clin Cancer Res 12, 4095 (2006); Sharma, S. et al. J Immunol 177, 8348 (2006); Wingender, G. et al. Eur J Immunol 36, 12 (2006); Gambotto, A. et al. Gene Ther 7, 2036 (2000).